sumatriptan has been researched along with Dysmenorrhea in 5 studies
Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.
Dysmenorrhea: Painful menstruation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the impact of a sumatriptan/naproxen sodium combination tablet on patient satisfaction, productivity, and functional disability in menstrual migraine treated during the mild pain phase of a single menstrual migraine attack associated with dysmenorrhea." | 9.15 | Sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea: satisfaction, productivity, and functional disability outcomes. ( Ballard, JE; Cady, RK; Derosier, FJ; Diamond, ML; Diamond, MP; Dorner, DP; Lener, ME; McDonald, SA; Runken, MC; White, J, 2011) |
| "To evaluate the efficacy and tolerability of sumatriptan-naproxen during the mild pain phase of a single menstrual migraine attack associated with dysmenorrhea." | 9.14 | Combination treatment for menstrual migraine and dysmenorrhea using sumatriptan-naproxen: two randomized controlled trials. ( Cady, RK; Derosier, FJ; Diamond, ML; Lener, SE; Mannix, LK; Martin, VT; McDonald, SA; White, JD, 2009) |
| "Menstrual migraine (MM) is a form of headache that tends to occur with prolonged, intense and extremely disabling attacks in a short period around the menstrual cycle (usually 2 days before to 3 days after the onset of the menstrual flow)." | 6.47 | Evaluation of the use of sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea. ( Allais, G; Benedetto, C; Castagnoli Gabellari, I; Rolando, S, 2011) |
| "To evaluate the impact of a sumatriptan/naproxen sodium combination tablet on patient satisfaction, productivity, and functional disability in menstrual migraine treated during the mild pain phase of a single menstrual migraine attack associated with dysmenorrhea." | 5.15 | Sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea: satisfaction, productivity, and functional disability outcomes. ( Ballard, JE; Cady, RK; Derosier, FJ; Diamond, ML; Diamond, MP; Dorner, DP; Lener, ME; McDonald, SA; Runken, MC; White, J, 2011) |
| "To evaluate the efficacy and tolerability of sumatriptan-naproxen during the mild pain phase of a single menstrual migraine attack associated with dysmenorrhea." | 5.14 | Combination treatment for menstrual migraine and dysmenorrhea using sumatriptan-naproxen: two randomized controlled trials. ( Cady, RK; Derosier, FJ; Diamond, ML; Lener, SE; Mannix, LK; Martin, VT; McDonald, SA; White, JD, 2009) |
| "To measure prostaglandin levels in the saliva of individuals during menstrual migraine associated with dysmenorrhea (MMaD) and in response to treatment with a single tablet combination of sumatriptan succinate and naproxen sodium." | 5.14 | Changes in salivary prostaglandin levels during menstrual migraine with associated dysmenorrhea. ( Cady, R; Derosier, F; Durham, PL; Martin, V; McDonald, S; Vause, CV, 2010) |
| "Data were pooled from two replicate randomized controlled trials of 621 adult menstrual migraineurs with dysmenorrhea who treated migraine with sumatriptan-naproxen or placebo." | 3.80 | Relief of menstrual symptoms and migraine with a single-tablet formulation of sumatriptan and naproxen sodium. ( Ballard, J; Derosier, FJ; Diamond, MP; Krishen, A; Lener, SE; Mannix, LK; Martin, VT; McDonald, SA, 2014) |
| "Menstrual migraine (MM) is a form of headache that tends to occur with prolonged, intense and extremely disabling attacks in a short period around the menstrual cycle (usually 2 days before to 3 days after the onset of the menstrual flow)." | 2.47 | Evaluation of the use of sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea. ( Allais, G; Benedetto, C; Castagnoli Gabellari, I; Rolando, S, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martin, VT | 2 |
| Ballard, J | 1 |
| Diamond, MP | 2 |
| Mannix, LK | 2 |
| Derosier, FJ | 3 |
| Lener, SE | 2 |
| Krishen, A | 1 |
| McDonald, SA | 3 |
| Cady, RK | 2 |
| Diamond, ML | 2 |
| White, JD | 1 |
| Durham, PL | 1 |
| Vause, CV | 1 |
| Derosier, F | 1 |
| McDonald, S | 1 |
| Cady, R | 1 |
| Martin, V | 1 |
| Ballard, JE | 1 |
| Lener, ME | 1 |
| Dorner, DP | 1 |
| White, J | 1 |
| Runken, MC | 1 |
| Allais, G | 1 |
| Castagnoli Gabellari, I | 1 |
| Rolando, S | 1 |
| Benedetto, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized, Double-blind, Single Migraine Attack, Placebo-controlled, Parallel-group Multicenter Study to Evaluate the Efficacy and Tolerability of Trexima (Sumatriptan Succinate.Naproxen Sodium) Tablets vs Placebo When Administered During the Mild Pain[NCT00329355] | Phase 3 | 351 participants (Actual) | Interventional | 2006-05-31 | Completed | ||
| A Randomized, Double-blind, Single Migraine Attack, Placebo -Controlled, Patallel-group Multicenter Study to Evaluate the Efficacy and Tolerability or Trexima (Sumatriptan Succinate/Naproxen Sodium) Tablets vs Placebo When Administered During the Mild Pai[NCT00329459] | Phase 3 | 320 participants (Actual) | Interventional | 2006-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for sumatriptan and Dysmenorrhea
| Article | Year |
|---|---|
Evaluation of the use of sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea.
Topics: Dysmenorrhea; Female; Humans; Menstrual Cycle; Migraine Disorders; Naproxen; Prostaglandins; Seroton | 2011 |
3 trials available for sumatriptan and Dysmenorrhea
| Article | Year |
|---|---|
Combination treatment for menstrual migraine and dysmenorrhea using sumatriptan-naproxen: two randomized controlled trials.
Topics: Administration, Oral; Adult; Double-Blind Method; Drug Combinations; Dysmenorrhea; Female; Humans; M | 2009 |
Combination treatment for menstrual migraine and dysmenorrhea using sumatriptan-naproxen: two randomized controlled trials.
Topics: Administration, Oral; Adult; Double-Blind Method; Drug Combinations; Dysmenorrhea; Female; Humans; M | 2009 |
Combination treatment for menstrual migraine and dysmenorrhea using sumatriptan-naproxen: two randomized controlled trials.
Topics: Administration, Oral; Adult; Double-Blind Method; Drug Combinations; Dysmenorrhea; Female; Humans; M | 2009 |
Combination treatment for menstrual migraine and dysmenorrhea using sumatriptan-naproxen: two randomized controlled trials.
Topics: Administration, Oral; Adult; Double-Blind Method; Drug Combinations; Dysmenorrhea; Female; Humans; M | 2009 |
Changes in salivary prostaglandin levels during menstrual migraine with associated dysmenorrhea.
Topics: Adult; Double-Blind Method; Dysmenorrhea; Female; Humans; Middle Aged; Migraine Disorders; Naproxen; | 2010 |
Changes in salivary prostaglandin levels during menstrual migraine with associated dysmenorrhea.
Topics: Adult; Double-Blind Method; Dysmenorrhea; Female; Humans; Middle Aged; Migraine Disorders; Naproxen; | 2010 |
Changes in salivary prostaglandin levels during menstrual migraine with associated dysmenorrhea.
Topics: Adult; Double-Blind Method; Dysmenorrhea; Female; Humans; Middle Aged; Migraine Disorders; Naproxen; | 2010 |
Changes in salivary prostaglandin levels during menstrual migraine with associated dysmenorrhea.
Topics: Adult; Double-Blind Method; Dysmenorrhea; Female; Humans; Middle Aged; Migraine Disorders; Naproxen; | 2010 |
Sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea: satisfaction, productivity, and functional disability outcomes.
Topics: Adult; Analgesics; Double-Blind Method; Drug Combinations; Dysmenorrhea; Female; Humans; Migraine Di | 2011 |
Sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea: satisfaction, productivity, and functional disability outcomes.
Topics: Adult; Analgesics; Double-Blind Method; Drug Combinations; Dysmenorrhea; Female; Humans; Migraine Di | 2011 |
Sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea: satisfaction, productivity, and functional disability outcomes.
Topics: Adult; Analgesics; Double-Blind Method; Drug Combinations; Dysmenorrhea; Female; Humans; Migraine Di | 2011 |
Sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea: satisfaction, productivity, and functional disability outcomes.
Topics: Adult; Analgesics; Double-Blind Method; Drug Combinations; Dysmenorrhea; Female; Humans; Migraine Di | 2011 |
1 other study available for sumatriptan and Dysmenorrhea
| Article | Year |
|---|---|
Relief of menstrual symptoms and migraine with a single-tablet formulation of sumatriptan and naproxen sodium.
Topics: Adolescent; Adult; Analgesics; Drug Combinations; Dysmenorrhea; Female; Humans; Logistic Models; Mig | 2014 |
Relief of menstrual symptoms and migraine with a single-tablet formulation of sumatriptan and naproxen sodium.
Topics: Adolescent; Adult; Analgesics; Drug Combinations; Dysmenorrhea; Female; Humans; Logistic Models; Mig | 2014 |
Relief of menstrual symptoms and migraine with a single-tablet formulation of sumatriptan and naproxen sodium.
Topics: Adolescent; Adult; Analgesics; Drug Combinations; Dysmenorrhea; Female; Humans; Logistic Models; Mig | 2014 |
Relief of menstrual symptoms and migraine with a single-tablet formulation of sumatriptan and naproxen sodium.
Topics: Adolescent; Adult; Analgesics; Drug Combinations; Dysmenorrhea; Female; Humans; Logistic Models; Mig | 2014 |